🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Canada / NCT03405779
Recruiting Observational

A New Ultrasonographic Tool to Assess Pulmonary Strain in the ICU

NCT03405779 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2018-03-12
Last updated
2025-09-18

Condition(s) studied

Mechanical Ventilation ComplicationVentilator-Induced Lung Injury

Investigational drug(s) / intervention(s)

Lung ultrasonography

Lung ultrasonography: Mechanically ventilated patients suffering from pulmonary diseases will undergo a lung ultrasonography during their stay in the intensive care unit (ICU)

Study summary

The primary objective of the study is to create a small dataset of regional pulmonary strain values in patients suffering from pulmonary diseases under mechanical ventilation in an intensive care setting.

Hypothesis: The analysis of lung ultrasonographic sequences using speckle-tracking allows the determination of local pleural strain in 4 predetermined pulmonary areas in mechanically ventilated patients suffering from pulmonary diseases.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult intensive care patients under mechanical ventilation suffering from a pulmonary disease with a static lung compliance of less than 40 mL/cm H2O. Exclusion Criteria: * Obesity (Body Mass Index superior to 30 kg/m2) * Previous thoracic procedure (chest tube, thoracotomy, thoracoscopy) * Intra-abdominal pressure inferior to 15 mm Hg (if available) * Previous participation to the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Centre Hospitalier de l'Université de Montréal (CHUM) Montreal Quebec Recruiting

More Centre hospitalier de l'Université de Montréal (CHUM) trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03405779 on ClinicalTrials.gov ↗ ← All trials in Canada